Quoin Pharmaceuticals Ltd
QNRX6.860USD
+0.040+0.59%
收盘 08/04, 16:00（美东）报价延迟15分钟
141.22M总市值
亏损市盈率 TTM
关于 Quoin Pharmaceuticals Ltd 公司
Quoin Pharmaceuticals Ltd（前身为 Cellect Biotechnology Ltd）是一家总部位于以色列的专业制药公司，专注于开发和商业化治疗罕见病和孤儿病的治疗产品。该公司的首款主打产品是 QRX003，这是一种每日一次的外用乳液，由广谱丝氨酸蛋白酶抑制剂组成，采用专有的 Invisicare 技术配制而成，用于治疗 Netherton 综合征。该产品将用于治疗其他罕见的皮肤病，包括脱皮性皮肤综合征、SAM 综合征和掌跖角化病。Quoin 还在开发 QRX004 作为营养不良性大疱性表皮松解症的潜在治疗方法，以及 QRX006 作为尚未公开的罕见皮肤病的潜在疗法。
公司简介
公司代码QNRX
公司名称Quoin Pharmaceuticals Ltd
上市日期Nov 01, 1989
CEODr. Michael Myers, Ph.D.
员工数量3
证券类型Depository Receipt
年结日Nov 01
公司地址23 Hata'as Street
城市KFAR SABA
上市交易所NASDAQ Capital Market Consolidated
国家Israel
邮编44425
电话97299741444
网址https://quoinpharma.com/
公司代码QNRX
上市日期Nov 01, 1989
CEODr. Michael Myers, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Michael Myers, Ph.D.
Dr. Michael Myers, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
17.22K
--
Dr. Amos Ofer
Dr. Amos Ofer
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Dr. Amotz Nehushtan
Dr. Amotz Nehushtan
Vice President - Research & Development & Product Development
Vice President - Research & Development & Product Development
--
--
Mr. Eyal Leibovitz
Mr. Eyal Leibovitz
Chief Financial Officer
Chief Financial Officer
--
--
Mr. David L. Braun
Mr. David L. Braun
Independent Director
Independent Director
--
--
Ms. Ronit Biran
Ms. Ronit Biran
Independent Director
Independent Director
--
--
Mr. Jonathan Burgin, CPA
Mr. Jonathan Burgin, CPA
Independent External Director
Independent External Director
--
--
Mr. Jonathan Burgin, CPA
Mr. Jonathan Burgin, CPA
Independent External Director
Independent External Director
--
--
Mr. Yali Sheffi
Mr. Yali Sheffi
Independent External Director
Independent External Director
--
--
Mr. Guy Sapir
Mr. Guy Sapir
Internal Auditor
Internal Auditor
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Michael Myers, Ph.D.
Dr. Michael Myers, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
17.22K
--
Dr. Amos Ofer
Dr. Amos Ofer
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Dr. Amotz Nehushtan
Dr. Amotz Nehushtan
Vice President - Research & Development & Product Development
Vice President - Research & Development & Product Development
--
--
Mr. Eyal Leibovitz
Mr. Eyal Leibovitz
Chief Financial Officer
Chief Financial Officer
--
--
Mr. David L. Braun
Mr. David L. Braun
Independent Director
Independent Director
--
--
Ms. Ronit Biran
Ms. Ronit Biran
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月26日 周六
更新时间: 7月26日 周六
持股股东
股东类型
持股股东
持股股东
占比
Myers (Michael)
2.93%
Carter (Denise P)
2.93%
UBS Financial Services, Inc.
1.07%
Dunn (Gordon)
0.73%
Culverwell (Anthony James)
0.49%
Other
91.86%
持股股东
持股股东
占比
Myers (Michael)
2.93%
Carter (Denise P)
2.93%
UBS Financial Services, Inc.
1.07%
Dunn (Gordon)
0.73%
Culverwell (Anthony James)
0.49%
Other
91.86%
股东类型
持股股东
占比
Individual Investor
7.08%
Investment Advisor
1.44%
Investment Advisor/Hedge Fund
0.16%
Other
91.32%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
33
51.05K
8.68%
-35.06K
2025Q1
35
78.22K
9.34%
-7.90K
2024Q4
33
2.93M
35.77%
+2.56M
2024Q3
29
288.95K
5.54%
-93.09K
2024Q2
30
301.96K
12.37%
-13.30K
2024Q1
28
276.13K
11.96%
+132.88K
2023Q4
28
104.03K
10.54%
-33.36K
2023Q3
27
83.72K
8.48%
+6.49K
2023Q2
28
91.62K
18.66%
+37.20K
2023Q1
30
101.74K
19.68%
+59.45K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Myers (Michael)
17.22K
2.93%
--
--
Mar 10, 2025
Carter (Denise P)
17.22K
2.93%
+1.00
+0.01%
Mar 10, 2025
UBS Financial Services, Inc.
6.27K
1.07%
+6.13K
+4507.35%
Mar 31, 2025
Dunn (Gordon)
4.32K
0.73%
--
--
Mar 10, 2025
Culverwell (Anthony James)
2.87K
0.49%
+2.86K
+31744.44%
Mar 10, 2025
Rhumbline Advisers Ltd. Partnership
1.19K
0.2%
+504.00
+73.15%
Mar 31, 2025
Raymond James Financial Services Advisors, Inc.
718.00
0.12%
--
--
Mar 31, 2025
Lido Advisors, LLC
672.00
0.11%
+672.00
--
Mar 31, 2025
Susquehanna International Group, LLP
320.00
0.05%
+320.00
--
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Mar 26, 2025
Merger
20<1
Jun 28, 2023
Merger
12<1
Jun 28, 2023
Merger
12<1
Jun 28, 2023
Merger
12<1
Jun 28, 2023
Merger
12<1
Jul 29, 2022
Merger
12.5<1
公告日期
类型
比率
Mar 26, 2025
Merger
20<1
Jun 28, 2023
Merger
12<1
Jun 28, 2023
Merger
12<1
Jun 28, 2023
Merger
12<1
Jun 28, 2023
Merger
12<1
Jul 29, 2022
Merger
12.5<1
Jul 29, 2022
Merger
12.5<1
Jul 29, 2022
Merger
12.5<1
Jul 29, 2022
Merger
12.5<1
Sep 23, 2021
Merger
4<1
查看更多
